Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2011) 26 P272

ECE2011 Poster Presentations Pituitary (111 abstracts)

Topoisomerase II α expression in human pituitary adenomas as the prognostic factor

M Trofimiuk 1 , G Sokolowski 1 , F Golkowski 1 , D Adamek 2 & A Hubalewska-Dydejczyk 1


1Endocrinology Department, Jagiellonian University, Collegium Medicum, Krakow, Poland; 2Pathology Department, Jagiellonian University, Collegium Medicum, Krakow, Poland.


Pituitary adenomas represent more than 80% of all sella turcica tumors and 10–15% of all intracranial tumors in adults. Topoisomerase II α (TopoIIα) is recognized as a reliable tumor proliferative activity marker. Evaluation of its expression facilitates the identification of more aggressive neoplasms.

Aim: To assess the topoIIα expression in pituitary adenomas as the marker of the tumor aggressiveness, recurrence and progression.

Material and methods: Retrospective study included 60 patients (23 males, 37 females; aged 46.7±17.6 years) operated due to pituitary adenoma, followed-up for 2 years after the surgery. TopoIIα nuclear expression was assessed immunohistochemically in tissue samples in , hot spot’ areas and indexed as % of all nuclei. The tumor recurrence, seen in 36.7% of patients, was assessed on repeated pituitary MRIs.

Results: 73% of samples stained for topoIIα (median index of 0.71%). The statistically significant difference in topoIIα indices was noted between non-secreting and secreting adenomas (0.8 vs 0.41%). The topoIIα indices were also statistically higher in macroadenomas, in tumors causing visual impairment, invading the suprasellar space and cavernous sinuses. TopoIIα index >1% was independent risk factor of tumor recurrence or progression (RR – 4.65, 95% CI – 1.80–11.51); visual chiasm involvement (RR – 5.04, 95% CI 1.11–22.90), cavernous sinuses invasion (RR – 5.22, 95% CI 1.24–21.89), but not of suprasellar growth (RR – 4.01, 95% CI 0.94–17.10). The sensitivity and specificity of the topoIIα index >1% in predicting pituitary adenoma recurrence was 63.6 and 86.8 respectively (area under ROC curve 0.76).

Conclusions: The topoIIα expression in pituitary adenomas is related to the more aggressive tumor behavior. The index of topoIIα higher than 1% is independent risk factor of early pituitary adenoma recurrence and progression. The topoIIα expression should be routinely assessed in pituitary adenomas, as it gives important prognostic data.

Article tools

My recent searches

No recent searches.